PULSAR Effect: Revealing potential synergies in combined radiation therapy and immunotherapy via differential equations

被引:0
|
作者
Rouf, Samiha [1 ]
Moore, Casey [2 ]
Saha, Debabrata [2 ]
Nguyen, Dan [2 ]
Bleile, Marylena [1 ,3 ]
Timmerman, Robert [2 ]
Peng, Hao [1 ,2 ]
Jiang, Steve [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr, Med Artificial Intelligence & Automat Lab, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr, Dept Radiat Oncol, Dallas, TX 75390 USA
[3] Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA
关键词
PULSAR; Immunotherapy; Mathematical model; Tumor growth; Murine trials; Tumor microenvironment;
D O I
10.1016/j.jtbi.2024.111974
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
PULSAR (personalized ultrafractionated stereotactic adaptive radiotherapy) is a form of radiotherapy method where a patient is given a large dose or "pulse" of radiation a couple of weeks apart rather than daily small doses. The tumor response is then monitored to determine when the subsequent pulse should be given. Pre-clinical trials have shown better tumor response in mice that received immunotherapy along with pulses spaced 10 days apart. However, this was not the case when the pulses were 1 or 4 days apart. Therefore, a synergistic effect between immunotherapy and PULSAR is observed when the pulses are spaced out by a certain number of days. In our study, we aimed to develop a mathematical model that can capture the synergistic effect by considering a timedependent weight function that takes into account the spacing between pulses. We determined feasible parameters by fitting murine tumor volume data of six treatment groups via simulated annealing algorithm. Applying these parameters to the model we simulated 4000 trials with varying sequencing of pulses. These simulations indicated that if pulses were spaced apart by at least 9 days the tumor volume was about 200 mm3 to 250 mm3 smaller when treated with PULSAR combined with immunotherapy. We successfully demonstrate that our model is simple to implement and can generate tumor volume data that is consistent with the pre-clinical trial data. Our model has the potential to aid in the development of clinical trials of PULSAR therapy.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
    Ukleja, Jacob
    Kusaka, Erika
    Miyamoto, David T.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Potential Synergies for Combined Targeted Therapy in the Treatment of Neuroendocrine Cancer
    Salazar, Ramon
    Reidy-Lagunes, Diane
    Yao, James
    DRUGS, 2011, 71 (07) : 841 - 852
  • [3] Potential Synergies for Combined Targeted Therapy in the Treatment of Neuroendocrine Cancer
    Ramon Salazar
    Diane Reidy-Lagunes
    James Yao
    Drugs, 2011, 71 : 841 - 852
  • [4] Radiation therapy and immunotherapy: Implications for a combined cancer treatment
    Levy, Antonin
    Chargari, Cyrus
    Cheminant, Morgane
    Simon, Noemie
    Bourgier, Celine
    Deutsch, Eric
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 278 - 287
  • [5] Combined radiation therapy and immunotherapy including blockade of immune checkpoint
    Akimoto, Tetsuo
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors
    Brooks, Eric D.
    Schoenhals, Jonathan E.
    Tang, Chad
    Micevic, Goran
    Gomez, Daniel R.
    Chang, Joe Y.
    Welsh, James W.
    CANCER JOURNAL, 2016, 22 (04): : 257 - 266
  • [7] The potential of BRAF-targeted therapy combined with immunotherapy in melanoma
    Naderi-Azad, Sheida
    Sullivan, Ryan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (02) : 131 - 136
  • [8] Radiation therapy and immunotherapy-a potential combination in cancer treatment
    Asna, N.
    Livoff, A.
    Batash, R.
    Debbi, R.
    Schaffer, P.
    Rivkind, T.
    Schaffer, M.
    CURRENT ONCOLOGY, 2018, 25 (05) : E454 - E460
  • [9] Stereotactic Radiation Therapy Combined With Immunotherapy: Augmenting the Role of Radiation in Local and Systemic Treatment
    Sharabi, Andrew B.
    Tran, Phuoc T.
    Lim, Michael
    Drake, Charles G.
    DeWeese, Theodore L.
    ONCOLOGY-NEW YORK, 2015, 29 (05): : 331 - 340
  • [10] Preclinical Advances in Combined-Modality Cancer Immunotherapy With Radiation Therapy
    Smith, Clayton A.
    Freeman, Michael L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 11 - 14